Creative Medical Technology Holdings, Inc. (NasdaqCM:CELZ) announces a share repurchase program. Under the program, the company will repurchase up to $2 million worth of its outstanding common stock. The program has no expiry date.
Creative Medical Technology Holdings, Inc.
Equities
CELZ
US22529Y4089
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.55 USD | +6.61% |
|
-14.66% | -22.99% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.99% | 4.79M | |
+15.19% | 121B | |
+19.91% | 114B | |
+8.24% | 23.61B | |
-19.80% | 20.43B | |
-16.19% | 16.55B | |
-13.45% | 16.45B | |
-44.35% | 15.59B | |
+66.67% | 15.19B | |
+2.13% | 13.54B |
- Stock Market
- Equities
- CELZ Stock
- News Creative Medical Technology Holdings, Inc.
- Creative Medical Technology Holdings, Inc. announces an Equity Buyback for $2 million worth of its shares.